---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290096308.md"
description: "Opus Genetics shares are trading higher after HC Wainwright & Co. reiterated its Buy rating on the stock and maintained a $8 price target."
datetime: "2026-06-17T17:04:15.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290096308.md)
  - [en](https://longbridge.com/en/news/290096308.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290096308.md)
generator: "portal-rs"
---

# 

Opus Genetics shares are trading higher after HC Wainwright & Co. reiterated its Buy rating on the stock and maintained a $8 price target.

### Related Stocks

- [IRD.US](https://longbridge.com/en/quote/IRD.US.md)

## Related News & Research

- [Opus Genetics: FDA-Backed Phase 3 Path and Strong Early Efficacy Support Reiterated Buy on IRD with Unchanged $10 Price Target](https://longbridge.com/en/news/291831058.md)
- [Cantor Fitzgerald Reaffirms Their Buy Rating on Opus Genetics (IRD)](https://longbridge.com/en/news/292316425.md)
- [67,254 Shares in OP Bancorp $OPBK Bought by Empowered Funds LLC](https://longbridge.com/en/news/298101333.md)
- [Brokers Set Expectations for Opus Genetics FY2030 Earnings](https://longbridge.com/en/news/295653446.md)
- [Barclays Reaffirms Their Hold Rating on Novan (NOVN)](https://longbridge.com/en/news/298282232.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**